Weld Capital Management’s Integra LifeSciences IART Stock Holding History

Weld Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,802	Closed	-$455K	–	559
2019 Q4	$455K	Buy	+7,802	New	+$464K	0.09%	380
2019 Q3	–	Sell	-7,510	Closed	-$419K	–	871
2019 Q2	$419K	Buy	+7,510	New	+$387K	0.08%	444

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Weld Capital Management's IART Position: Q1 2020 in Review

Weld Capital Management sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 7,802 shares — an estimated $455K sold.

Weld Capital Management first reported a position in IART in Q2 2019 and held it in 2 quarters. The position peaked at $455K in Q4 2019. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Weld Capital Management reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Weld Capital Management sold 7,802 Integra LifeSciences shares in Q1 2020, an estimated $455K.
Weld Capital Management first reported a position in Integra LifeSciences in Q2 2019 and held it in 2 quarters.
Weld Capital Management's Integra LifeSciences position peaked at $455K in Q4 2019.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Weld Capital Management's 13F filing for Q1 2020, filed 15 May 2020.